RNA m6A methylation regulators in ovarian cancer

Abstract N6-methyladenosine (m6A) is the most abundant RNA modification of mammalian mRNAs and plays a vital role in many diseases, especially tumours. In recent years, m6A has become the topic of intense discussion in epigenetics. M6A modification is dynamically regulated by methyltransferases, dem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jialu Guo, Jianfeng Zheng, Huizhi Zhang, Jinyi Tong
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/8109343cc80e4d1d97e0ce7a290795f2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8109343cc80e4d1d97e0ce7a290795f2
record_format dspace
spelling oai:doaj.org-article:8109343cc80e4d1d97e0ce7a290795f22021-11-21T12:39:36ZRNA m6A methylation regulators in ovarian cancer10.1186/s12935-021-02318-81475-2867https://doaj.org/article/8109343cc80e4d1d97e0ce7a290795f22021-11-01T00:00:00Zhttps://doi.org/10.1186/s12935-021-02318-8https://doaj.org/toc/1475-2867Abstract N6-methyladenosine (m6A) is the most abundant RNA modification of mammalian mRNAs and plays a vital role in many diseases, especially tumours. In recent years, m6A has become the topic of intense discussion in epigenetics. M6A modification is dynamically regulated by methyltransferases, demethylases and RNA-binding proteins. Ovarian cancer (OC) is a common but highly fatal malignancy in female. Increasing evidence shows that changes in m6A levels and the dysregulation of m6A regulators are associated with the occurrence, development or prognosis of OC. In this review, the latest studies on m6A and its regulators in OC have been summarized, and we focus on the key role of m6A modification in the development and progression of OC. Additionally, we also discuss the potential use of m6A modification and its regulators in the diagnosis and treatment of OC.Jialu GuoJianfeng ZhengHuizhi ZhangJinyi TongBMCarticleOvarian cancerBiomarkerN6-methyladenosineRegulatorsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282CytologyQH573-671ENCancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Ovarian cancer
Biomarker
N6-methyladenosine
Regulators
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
spellingShingle Ovarian cancer
Biomarker
N6-methyladenosine
Regulators
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
Jialu Guo
Jianfeng Zheng
Huizhi Zhang
Jinyi Tong
RNA m6A methylation regulators in ovarian cancer
description Abstract N6-methyladenosine (m6A) is the most abundant RNA modification of mammalian mRNAs and plays a vital role in many diseases, especially tumours. In recent years, m6A has become the topic of intense discussion in epigenetics. M6A modification is dynamically regulated by methyltransferases, demethylases and RNA-binding proteins. Ovarian cancer (OC) is a common but highly fatal malignancy in female. Increasing evidence shows that changes in m6A levels and the dysregulation of m6A regulators are associated with the occurrence, development or prognosis of OC. In this review, the latest studies on m6A and its regulators in OC have been summarized, and we focus on the key role of m6A modification in the development and progression of OC. Additionally, we also discuss the potential use of m6A modification and its regulators in the diagnosis and treatment of OC.
format article
author Jialu Guo
Jianfeng Zheng
Huizhi Zhang
Jinyi Tong
author_facet Jialu Guo
Jianfeng Zheng
Huizhi Zhang
Jinyi Tong
author_sort Jialu Guo
title RNA m6A methylation regulators in ovarian cancer
title_short RNA m6A methylation regulators in ovarian cancer
title_full RNA m6A methylation regulators in ovarian cancer
title_fullStr RNA m6A methylation regulators in ovarian cancer
title_full_unstemmed RNA m6A methylation regulators in ovarian cancer
title_sort rna m6a methylation regulators in ovarian cancer
publisher BMC
publishDate 2021
url https://doaj.org/article/8109343cc80e4d1d97e0ce7a290795f2
work_keys_str_mv AT jialuguo rnam6amethylationregulatorsinovariancancer
AT jianfengzheng rnam6amethylationregulatorsinovariancancer
AT huizhizhang rnam6amethylationregulatorsinovariancancer
AT jinyitong rnam6amethylationregulatorsinovariancancer
_version_ 1718418894527397888